Rodent Models of Optic Neuritis

被引:12
|
作者
Redler, Yael [1 ]
Levy, Michael [2 ]
机构
[1] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Neuroophthalmol, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
基金
美国国家卫生研究院;
关键词
optic neuritis; rodent models; experimental autoimmune encephalomyelitis; multiple sclerosis; demyelination; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALPHA-LIPOIC ACID; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; T-CELLS; DEMYELINATED LESIONS; NEURONAL APOPTOSIS; PASSIVE TRANSFER; VISUAL FUNCTION; ANIMAL-MODELS;
D O I
10.3389/fneur.2020.580951
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Optic neuritis (ON) is an inflammatory attack of the optic nerve that leads to visual disability. It is the most common optic neuropathy affecting healthy young adults, most commonly women aged 20-45 years. It can be idiopathic and monophasic or as part of a neurologic disease such as multiple sclerosis with recurrence and cumulative damage. Currently, there is no therapy to repair the damage from optic neuritis. Animal models are an essential tool for the understanding of the pathogenesis of optic neuritis and for the development of potential treatment strategies. Experimental autoimmune encephalomyelitis (EAE) is the most commonly used experimental rodent model for human autoimmune inflammatory demyelinating diseases of the central nervous system (CNS). In this review, we discuss the latest rodent models regarding optic neuritis, focusing on EAE model, and on its recent achievements and developments.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Experimental optic neuritis induced by the microinjection of lipopolysaccharide into the optic nerve
    Aranda, Marcos L.
    Dorfman, Damian
    Sande, Pablo H.
    Rosenstein, Ruth E.
    EXPERIMENTAL NEUROLOGY, 2015, 266 : 30 - 41
  • [2] Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats
    Das, Arabinda
    Guyton, M. Kelly
    Smith, Amena
    Wallace, Gerald
    McDowell, Misty L.
    Matzelle, Denise D.
    Ray, Swapan K.
    Banik, Naren L.
    JOURNAL OF NEUROCHEMISTRY, 2013, 124 (01) : 133 - 146
  • [3] Optic Neuritis
    Clark, David
    Kebede, Workayehu
    Eggenberger, Eric
    NEUROLOGIC CLINICS, 2010, 28 (03) : 573 - +
  • [4] Optic neuritis
    Pau, D.
    Al Zubidi, N.
    Yalamanchili, S.
    Plant, G. T.
    Lee, A. G.
    EYE, 2011, 25 (07) : 832 - 841
  • [5] Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis
    Brambilla, Roberta
    Dvoriantchikova, Galina
    Barakat, David
    Ivanov, Dmitry
    Bethea, John R.
    Shestopalov, Valery I.
    JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [6] Overview of diet and autoimmune demyelinating optic neuritis: a narrative review
    Plafker, Scott M.
    Titcomb, Tyler
    Zyla-Jackson, Katarzyna
    Kolakowska, Aneta
    Wahls, Terry
    IMMUNOMETABOLISM, 2023, 5 (02) : E00022
  • [7] Management of optic neuritis
    Menon, Vimla
    Saxena, Rohit
    Misra, Ruby
    Phuljhele, Swati
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2011, 59 (02) : 117 - 122
  • [8] An update on optic neuritis
    Kraker, Jessica A.
    Chen, John J.
    JOURNAL OF NEUROLOGY, 2023, 270 (10) : 5113 - 5126
  • [9] Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis
    Liu, Qiang
    Li, Haining
    Yang, Juan
    Niu, Xiaoyan
    Zhao, Chunmei
    Zhao, Li
    Wang, Zhenhai
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 1363 - 1370
  • [10] Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects
    Dietrich, Michael
    Aktas, Orhan
    Hartung, Hans-Peter
    Albrecht, Philipp
    CURRENT OPINION IN NEUROLOGY, 2019, 32 (03) : 346 - 357